Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel63

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel19

Views

Views
December 20253
January 20263
February 20260
March 20262
April 20261
May 20265
June 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Argentina2
Colombia1
Netherlands1
Panama1
Paraguay1
Singapore1
Tunisia1
Turkey1
Uruguay1
 

Top cities views

Views
San Jose3
Antalya1
Barranquilla1
Groningen1
Jackson1
La Plata1
Lomas de Zamora1
Montevideo1
Nabeul1
Philadelphia1